Immunogenicity and clinical activity of a polyvalent melanoma antigen vaccine prepared from shed antigens.
Bystryn
J C
JC
Department of Dermatology, Kaplan Comprehensive Cancer Center, New York University School of Medicine, New York 10016.
D000818:Animals; D000912:Antibodies, Neoplasm / Q000276:immunology; D000951:Antigens, Neoplasm / Q000276:immunology*; D003602:Cytotoxicity, Immunologic; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007111:Immunity, Cellular; D016233:Immunotherapy, Active / Q000379:methods*; D015993:Life Tables; D008545:Melanoma / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D051379:Mice; D008810:Mice, Inbred C57BL; D016019:Survival Analysis; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014407:Tumor Cells, Cultured
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm